Letrezole or clomide for ovulation induction in patients with unexplained infertility.
Abstract
Background:
The aim of our study to compare the efficacy of letrezole to clomiphene citrate in patient with unexplained infertility as empirical treatment.
Methods:
200 patients with unexplained infertility randomly divided into two groups the first group received( 5mg letrezole from the day 3-7 of menstrual cycle), the second group received (100 mg clomiphene citrate from the day 2-5 of menstrual cycle), follicular development followed by serial U/S, when one or more follicles reach > 18mm in diameter ovulation trigger by hCG and timed intercourse was advise later on . Pregnancy test was performed 5 days after the miss period to confirm the pregnancy, the main outcome was the pregnancy rate and the secondary outcome was follicle development and endometrial thickness.
Result:
Both groups were comparable regarding the ovulation rate (62.5% in the group B ( clomid group ) and 75.2% in group A ( letrezole group ) ( P = 0.35 ), the endometrial thickness was statistically significant difference in the letrzole group on day of HCG administration ( 6.6_+1.69 mm in the letrezole group, 5.4_+1.61 mm in the clomide group, P < 0.001). Serum estradiol was significantly lower in letrezole group ( 456_+150 versus 922_+301 pg/ml, P < 0.001). While the rate of multiple follicular development was greater in the group B ( clomide 55.15%, letrezole 25.41%, P=0.025), which was statistically significant. The pregnancy occurred in 36 out 100 (36% ) in letrezole group and 12 out 100 ( 12% ) in clomide group, the difference was highly statistically significant ( P < 0.025 ).
Conclusion:
Letrezole had a good efficacy and may be regard as first line treatment in patients with unexplained infertility in comparison with clomiphene citrate
References
-Kamath MS, Bhattacharya S. Demographics of infertility and management of unexplained infertility. Best Pract Res Clin Obstet Gynaecol 2012.
-Quaas, A. and Dokras, A. Diagnosis and Treatment of Unexplained Infertility. Reviews in Obstetrics Gynecology I, 2008, 69-76.
-The Practice Committee of the American Society for Reproductive Medicine. Effectiveness and treatment for unexplained infertility. Fertli Steril 2006; 86:111-4.
-Stephen EH, Chandra A. Updated projections of infertility in the United states: 1995-2025. Fertil Steril 1998; 70:30-4.
- The Practice Committee of the American Society for Reproductive Medicine, Optimal evaluation of infertile female. Fertli Steril 2006; 86: 264-7.
-Badawy A, El Nashar A, EI Totongy M. Clomiphene citrate plus N-acetyl cysteine versus clomiphene citrate for augmentation ovulation in the management of unexplained infertility : a randomized double-blind controlled trial. Fertli Steril 2006; 86: 647-70.
-Adashi EY. Clomiphene citrate: mechanism and site of action : hypotheses revisited. Fertli Steril, 1984; 42: 331-42.
- Practice Committee of the American Society for Reproductive Medicine. Use of Clomiphene citrate in women. Fertli Steril, 2006; 86(5 suppl 1):S 187-93.
-Dicky RP, Holtkamp DE. Development, pharmacology and clinical experience with clomiphene citrate. Hum Reprod Update 1996;2:483-506.
-Mukheriee S, Sharma S and Chakravarty BN. Comparative in Polycystic Ovarian Syndrome and Unexplained Infertility –A Prospective Clinical Trial. Journal of Human Reproductive Sciences,3,80-84.
-Homburg R. Clomiphene citrate-end of an era? A mini-review. Hum Reprod 2005; 8: 2043-51.
-Holzer H, Casper R, Tulandi T. A new era in ovulation induction. Fertil Steril 2006; 85: 277-284.
- Weil S, Vendola K, Zhou J, Bondy CA. Androgen and follicle-stimulating hormone interaction in primate ovarian follicle development. J Clin Endocrinol Metab 1999; 84:2951-2956.
-Topipat C, Choktanasiri W, Jultanmas R, et al. A comparison of the effects of clomiphene citrate and the aromatase inhibitor letrezole on superovulation in Asian women with normal ovulatory cycles. Gynecol Endocrinol 2008; 24: 145-150.
-Menkveld, R. Clinical significance of the low normal sperm morphology value as proposed in the fifth edition of the WHO laboratory manual for the examination and processing of human semen. Asian Journal of andrology, 2010; 12: 47-58.
-Gonen Y, Casper RF. Sonographic determination of a possible adverse effect of clomiphene citrate on endometrial growth. Hum Reprod 1990; 5:670-4.
- Eden JA, Place J, Carter GD, Jones J, Alaghband-Zadeh J, Pawson ME. The effect of clomiphene citrate on follicular phase increase in endometrial thickness and uterine volume. Obstet Gynecol. 1989;73:187-90.
-Weil SJ, Vendola K, Zhou J, Adesanya OO, Wang J, Okafor J, et al. Androgen receptor controlled ovarian hyperstimulation in the primate ovary: cellular localization, regulation, and functional correlation. J Clin Endocrinol Metab. 1998;83:2479-85.
- Sujata Kar. Clomiphene citrate or letrezole as first line ovulation induction drug in infertile PCOS women: A prospective randomized trial . J Hum. Reprod. Sci. 2012; 5(3): 262-265.
-Badawy A, Aal IA, Abulalta M. Clomiphene citrate or Letrezole for ovulation induction in women with poly cystic ovarian syndrome: A prospective randomized trial. Fertil Steril. 2009; 92:849-52.
-Bayar U, Tanriverdi HA, Aykut B, Ayoglu F, Ozcan O, Erdal K. Letrezole vs clomiphene citrate in patients with ovulatory infertility. Fertil Steril. 2006;85:1045-8.
-HaqNawas F, Virk S, Qadir T and Imam S. Comparison of letrezole and clomiphene citrate efficacy along with gonadotrophins in controlled ovarian hyperstimulation for intrauterine insemination cycles. Journal of reproduction and infertility, 2013;14:138-142.
-Usama M Fouda, Ahmed M Sayed. Extended regimen versus clomiphene citrate for super ovulation in patients with unexplained infertility undergoing intrauterine insemination: A randomized controlled trial. Reproductive biology and endocrinology 2011, 9:84.
-Mitwally MF, Casper RF. Use of an aromatase inhibitor for induction of ovulation in patients with an adequate response to clomiphene citrate. Fertil Steril. 2001, 75(2): 305-309.
-Sh Tehrani Nejad E, Abediasl Z, Rashidi BH, Azimi Nekoo E, Shariat M, Amirchagh maghi E. Comparison of the efficacy of the aromatase inhibitor letrezole and clomiphene citrate gonadotropins in controlled ovarian hyper stimulation:A prospective, simply randomized, clinical trial. J Assist Reprod Genet 2008, 25(5): 187-190.
-Badawy A, El Nashar A, EI Totongy M. Clomiphene citrate or aromatase inhibitors for super ovulation in women with unexplained infertility undergoing intrauterine insemination: a prospective randomized clinical trial. Fertil Steril. 2009, 92(4): 1355-135.
-Al-Fozan H, Al-Khadouri M, Tang SL, Tulandi T: A randomized trial of letrezole versus clomiphene citrate in women undergoing super ovulation. Fertil Steril 2004, 82(6): 1561-1563.
-Sherif F, Hendawy, Hanan E, Samaha and Mohamed F, Elkholy: letrezole versus clomiphene citrate for induction of ovulation in patients with polycystic ovarian syndrome undergoing intrauterine insemination. Clinical Medicine Insight: Reproductive Health 2011:511-16.
-Requena A, Herrero J, Landeras J, Navarro E, Neyro JL, Savador C, Tur R, Callejo J, Checa MA, Farre M, et al: use of letrezole in assisted reproduction: a systematic review and meta-analysis. Hum Reprod Update 2008, 14(6):571-582.
-Cortinez A, De Carvalho I, Vantman D, Gabler F, Iniguez G, Vega M: Hormonal profile and endometrial morphology in letrezole-controlled ovarian hyper stimulation in ovulatory infertile patients. Fertil Steril 2005, 83(1):110-115.
-Forman R, Gill S, Moretti M, Tulandi T, Koren G, Casper R: Fetal safety of letrezole and clomiphene citrate for ovulation induction. J Obstet Gynecol Can 2007, 29(8):668-671
